PuSH - Publikationsserver des Helmholtz Zentrums München

71 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
Alle Publikationen dieser Seite in den Korb legen
1.
Blank, S. & Hilger, C.*: Editorial: Novel advances in allergy diagnosis and treatment. Front. Immunol. 12:662699 (2021)
2.
Brand, I.* et al.: Broad T cell targeting of structural proteins after SARS-CoV-2 infection: High throughput assessment of T cell reactivity using an automated interferon gamma release assay. Front. Immunol. 12:688436 (2021)
3.
Chu, C.F.* et al.: Convalescent COVID-19 patients without comorbidities display similar immunophenotypes over time despite divergent disease severities. Front. Immunol. 12:601080 (2021)
4.
Cirac, A.* et al.: Immunoinformatic analysis reveals antigenic heterogeneity of Epstein-Barr virus is immune-driven. Front. Immunol. 12:796379 (2021)
5.
Grunewald, C.M.* et al.: Epigenetic priming of bladder cancer cells with decitabine increases cytotoxicity of human EGFR and CD44v6 CAR engineered T-cells. Front. Immunol. 12:782448 (2021)
6.
Holmen Olofsson, G.* et al.: Vγ9Vδ2 T cells concurrently kill cancer cells and cross-present tumor antigens. Front. Immunol. 12:645131 (2021)
7.
Hose, A.J.* et al.: Excessive unbalanced meat consumption in the first year of life increases asthma risk in the PASTURE and LUKAS2 birth cohorts. Front. Immunol. 12:651709 (2021)
8.
Klopp, A. et al.: Depletion of T cells via inducible caspase 9 increases safety of adoptive T-cell therapy against chronic hepatitis B. Front. Immunol. 12:734246 (2021)
9.
Körber, N. et al.: Hepatitis B vaccine non-responders show higher frequencies of CD24highCD38high regulatory B cells and lower levels of IL-10 expression compared to responders. Front. Immunol. 12:713351 (2021)
10.
Linder, A.* et al.: Defective interfering genomes and the full-length viral genome trigger RIG-I after infection with vesicular stomatitis virus in a replication dependent manner. Front. Immunol. 12:595390 (2021)
11.
Mishto, M.* ; Mansurkhodzhaev, A.* ; Rodriguez-Calvo, T. & Liepe, J.*: Potential mimicry of viral and pancreatic β cell antigens through non-spliced and cis-spliced zwitter epitope candidates in type 1 diabetes. Front. Immunol. 12:656451 (2021)
12.
Olguín-Contreras, L.F. ; Mendler, A.N. ; Popowicz, G.M. ; Hu, B. & Nößner, E.: Double strike approach for tumor attack: Engineering T cells using a CD40L:CD28 chimeric co-stimulatory switch protein for enhanced tumor targeting in adoptive cell therapy. Front. Immunol. 12:750478 (2021)
13.
Rodriguez-Calvo, T. ; Johnson, J.D.* ; Overbergh, L.* & Dunne, J.L.*: Neoepitopes in type 1 diabetes: Etiological insights, biomarkers and therapeutic targets. Front. Immunol. 12:667989 (2021)
14.
Rodriguez-Calvo, T. et al.: Means, motive, and opportunity: Do non-islet-reactive infiltrating T cells contribute to autoimmunity in type 1 diabetes? Front. Immunol. 12:683091 (2021)
15.
Schöllhorn, A.* et al.: Integrin activation enables sensitive detection of functional CD4+ and CD8+ T cells: Application to characterize SARS-CoV-2 immunity. Front. Immunol. 12:626308 (2021)
16.
Serr, I. ; Kral, M. ; Scherm, M.G. & Daniel, C.: Advances in human immune system mouse models for personalized treg-based immunotherapies. Front. Immunol. 12:643544 (2021)
17.
Serr, I. ; Drost, F.* ; Schubert, B. & Daniel, C.: Antigen-specific Treg therapy in type 1 diabetes - challenges and opportunities. Front. Immunol. 12:712870 (2021)
18.
von Mutius, E.: The “Hygiene Hypothesis” and the lessons learnt from farm studies. Front. Immunol. 12:635522 (2021)
19.
Watts, D. et al.: Transient depletion of Foxp3+ regulatory T cells selectively promotes aggressive β cell autoimmunity in genetically susceptible DEREG mice. Front. Immunol. 12:720133 (2021)
20.
Alessandrini, F. ; Musiol, S. ; Schneider, E. ; Blanco-Pérez, F.* & Albrecht, M.*: Mimicking antigen-driven asthma in rodent models-how close can we get? Front. Immunol. 11:575936 (2020)